Skip to content
Politically.com Search all
Menu

2026 · 3rd Quarter (July 1 - Sep 30)

MARSHALL BIORESOURCES

Filed by CHAMBER HILL STRATEGIES.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-10-28 06:26:13 UTC.

Source-reported fields

Filing overview

Type
3rd Quarter - Report
Posted
Oct 19, 2026
Income
$50,000.00
Expenses
Not reported
Filing UUID
72a0abdc-ea1b-4e36-b43e-0ff4a13dba7c
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

HCR · Health Issues

S. 5048/HR 7248, the FDA Modernization Act; issues related to pre-clinical research; HR 10522, the Companion Animal Protection Against Cruel Testing Act; HR 10532, the Beagle Liberation Act

Literal federal measure citations: S. 5048, HR 7248, HR 10522, HR 10532

ANI · Animals

HR 10523, the Prohibiting Unethical Procedures on Pets in Science Act; HR 10627, the Animal Welfare Enforcement Improvement Act

Literal federal measure citations: HR 10523, HR 10627

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.